Cargando…
Predicting clinical progression in multiple sclerosis after 6 and 12 years
BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590122/ https://www.ncbi.nlm.nih.gov/pubmed/30629788 http://dx.doi.org/10.1111/ene.13904 |
_version_ | 1783429489132306432 |
---|---|
author | Dekker, I. Eijlers, A. J. C. Popescu, V. Balk, L. J. Vrenken, H. Wattjes, M. P. Uitdehaag, B. M. J. Killestein, J. Geurts, J. J. G. Barkhof, F. Schoonheim, M. M. |
author_facet | Dekker, I. Eijlers, A. J. C. Popescu, V. Balk, L. J. Vrenken, H. Wattjes, M. P. Uitdehaag, B. M. J. Killestein, J. Geurts, J. J. G. Barkhof, F. Schoonheim, M. M. |
author_sort | Dekker, I. |
collection | PubMed |
description | BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years. Disability was measured using the Expanded Disability Status Scale (EDSS); cognition was measured only at follow‐up using neuropsychological testing. Predictors of interest included EDSS score, baseline brain and lesion volumes and their changes over 2 years, baseline age, clinical phenotype, sex and educational level. RESULTS: Higher 6‐year EDSS score was predicted by early EDSS score and whole‐brain volume changes and baseline diagnosis of primary progressive MS (adjusted R (2) = 0.56). Predictors for 12‐year EDSS score included larger EDSS score changes and higher T1‐hypointense lesion volumes (adjusted R (2) = 0.38). Year 6 cognition was predicted by primary progressive MS phenotype, lower educational level, male sex and early whole‐brain atrophy (adjusted R (2) = 0.26); year 12 predictors included male sex, lower educational level and higher baseline T1‐hypointense lesion volumes (adjusted R (2) = 0.14). CONCLUSIONS: Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures. |
format | Online Article Text |
id | pubmed-6590122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65901222019-07-08 Predicting clinical progression in multiple sclerosis after 6 and 12 years Dekker, I. Eijlers, A. J. C. Popescu, V. Balk, L. J. Vrenken, H. Wattjes, M. P. Uitdehaag, B. M. J. Killestein, J. Geurts, J. J. G. Barkhof, F. Schoonheim, M. M. Eur J Neurol Original Articles BACKGROUND AND PURPOSE: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. METHODS: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years. Disability was measured using the Expanded Disability Status Scale (EDSS); cognition was measured only at follow‐up using neuropsychological testing. Predictors of interest included EDSS score, baseline brain and lesion volumes and their changes over 2 years, baseline age, clinical phenotype, sex and educational level. RESULTS: Higher 6‐year EDSS score was predicted by early EDSS score and whole‐brain volume changes and baseline diagnosis of primary progressive MS (adjusted R (2) = 0.56). Predictors for 12‐year EDSS score included larger EDSS score changes and higher T1‐hypointense lesion volumes (adjusted R (2) = 0.38). Year 6 cognition was predicted by primary progressive MS phenotype, lower educational level, male sex and early whole‐brain atrophy (adjusted R (2) = 0.26); year 12 predictors included male sex, lower educational level and higher baseline T1‐hypointense lesion volumes (adjusted R (2) = 0.14). CONCLUSIONS: Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures. John Wiley and Sons Inc. 2019-02-02 2019-06 /pmc/articles/PMC6590122/ /pubmed/30629788 http://dx.doi.org/10.1111/ene.13904 Text en © 2019 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Dekker, I. Eijlers, A. J. C. Popescu, V. Balk, L. J. Vrenken, H. Wattjes, M. P. Uitdehaag, B. M. J. Killestein, J. Geurts, J. J. G. Barkhof, F. Schoonheim, M. M. Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title | Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title_full | Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title_fullStr | Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title_full_unstemmed | Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title_short | Predicting clinical progression in multiple sclerosis after 6 and 12 years |
title_sort | predicting clinical progression in multiple sclerosis after 6 and 12 years |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590122/ https://www.ncbi.nlm.nih.gov/pubmed/30629788 http://dx.doi.org/10.1111/ene.13904 |
work_keys_str_mv | AT dekkeri predictingclinicalprogressioninmultiplesclerosisafter6and12years AT eijlersajc predictingclinicalprogressioninmultiplesclerosisafter6and12years AT popescuv predictingclinicalprogressioninmultiplesclerosisafter6and12years AT balklj predictingclinicalprogressioninmultiplesclerosisafter6and12years AT vrenkenh predictingclinicalprogressioninmultiplesclerosisafter6and12years AT wattjesmp predictingclinicalprogressioninmultiplesclerosisafter6and12years AT uitdehaagbmj predictingclinicalprogressioninmultiplesclerosisafter6and12years AT killesteinj predictingclinicalprogressioninmultiplesclerosisafter6and12years AT geurtsjjg predictingclinicalprogressioninmultiplesclerosisafter6and12years AT barkhoff predictingclinicalprogressioninmultiplesclerosisafter6and12years AT schoonheimmm predictingclinicalprogressioninmultiplesclerosisafter6and12years |